MIT researchers have developed a new cell imaging technique that offers “the ability to observe up to seven different molecules simultaneously,” writes Amal Jos Chacko for Interesting Engineering. “This could open the door to a deeper understanding of cellular functions, aging, and diseases.”
The work of Professors David Autor and Daron Acemoglu is highlighted in an article for The Economist that examines “how jobs are being transformed for the better.” A recent paper co-authored by Autor “demonstrated that tight American labour markets are leading to fast wage growth,” while a study from Acemoglu and others found “that use of robots meant higher wages for workers who were not replaced, and that these benefits spread beyond the automating firms.”
Prof. Rudolf Jaenisch speaks with Fortune reporter Carolyn Barber about the immune system’s response to Covid-19. “The immune system is really stimulated–it’s in hyperdrive,” says Jaenisch.
MIT researchers have “used an algorithm to sort through millions of genomes to find new, rare types of CRISPR systems that could eventually be adapted into genome-editing tools,” writes Sara Reardon for Nature. “We are just amazed at the diversity of CRISPR systems,” says Prof. Feng Zhang. “Doing this analysis kind of allows us to kill two birds with one stone: both study biology and also potentially find useful things.”
MIT Sloan Lecturer Shira Springer speaks with WBUR host Robin Young about the future of women’s sports coverage. “It does require extra effort on the part of the fan to find coverage on the streaming platforms,” says Springer. “And that is a problem because what you are trying to do in women’s sports is convert casual fans to avid fans and maybe bring in people who simply were not aware of what women’s sports offers, and to do what you need to be easily discoverable.”
Prof. Adam Berinsky speaks with MSNBC’s Morning Joe about the impact of misinformation on democracy and the upcoming 2024 election. “The larger issue is that there is this climate of distrust,” says Berinsky.
Researchers from MIT and elsewhere have developed a swallowable “technopill” that can monitor vital signs from inside the body, reports Dennis Thompson for HealthDay. “The ability to facilitate diagnosis and monitor many conditions without having to go into a hospital can provide patients with easier access to healthcare and support treatment,” says Prof. Giovanni Traverso.
Principal Research Scientist Emre Gençer speaks with The Independent reporter Louise Boyle about natural hydrogen and its potential as a future renewable energy source. “There is a ‘mismatch’ where natural hydrogen is being discovered and where it could be used, which would require massive investments in completely new infrastructure,” says Gençer. “I think it will be part of the solution but we need to take it with a grain of salt.”
MIT researchers have developed a supercapacitor comprised of concrete and charcoal, that can store electricity and discharge as needed, reports Aleks Phillips for Newsweek. Researchers hope the device can provide “a cheap and architectural way of saving renewable energy from going to waste,” writes Phillips.
A team including researchers from MIT have developed a new ingestible ‘smart capsule’ that uses a patient’s vital signs to detect sleep disorders or opioid overdoses. “The findings suggest that the ingestible was able to measure health metrics on par with medical-grade diagnostic equipment at the sleep center,” writes Malak Saleh for Engadget.
Prof. Gio Traverso speaks with Lizzy Lawler at STAT about a new ingestible sensor that monitors a person’s heart and breathing rates to detect sleep disorders. “The vision for sleep evaluation is the ability to detect these events wherever you are in the nation, and not having to go to a sleep lab and an inpatient setting,” says Traverso.
New Scientist reporter Alice Klein writes that MIT researchers have developed an ingestible electronic device that “can measure your breathing and heart rate from inside your gut [and] could potentially diagnose sleep apnea and even detect opioid overdoses.” The device could one day allow “people to be assessed for sleep apnea wirelessly and cheaply while at home.”
Researchers at MIT and elsewhere have developed a new type of cancer treatment – a gel that can be used to deliver cancer drugs for solid tumors, reports WHDH. “It’s really transformative to try and help patients whose tumors are very resistant to therapy,” says Prof. Giovanni Traverso.
Researchers at MIT and elsewhere have developed a swallowable electronic capsule that can be used to help diagnose sleep apnea and other sleep disorders, reports Ian Randall for Newsweek. “Conventional laboratory and home sleep studies require the patient to be attached to many different sensors,” says Prof. Giovanni Traverso. “As you can imagine, trying to sleep with all of this machinery can be challenging. [The] ingestible capsule just requires that the patient swallow the vitamin-sized pill. It's easy and unobtrusive and can accurately measure both respiratory rate and heart rate while the patient sleeps."
Prof. Tavneet Suri discusses GiveDirectly, the world’s largest universal basic income (UBI) program, which has been providing almost 5,000 people in Kenya with “a payment of about 75 cents (62p) a day since 2017,” reports Philippa Kelley for The Guardian. “We do see people leaving low wage jobs,” says Suri. “They are going and starting businesses, and the businesses are doing great because there’s money around.”